Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 3, 2011, Pages 415-423

  Solans Laqué, Roser ^a   López Hernandez, Andrés ^a   Angel Bosch Gil, Josep ^a   Palacios, Andrés ^a   Campillo, Mercedes ^b   Vilardell Tarres, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hypocomplementemia; Lymphocytopenia; Lymphoma; Mortality; Primary Sj gren syndrome; Prognostic factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; DEATH; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPOCOMPLEMENTEMIA; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MORTALITY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PAROTID ENLARGEMENT; PREDICTION; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SJOEGREN SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; LYMPHOMA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK; RISK FACTORS; SJOGREN'S SYNDROME; SURVIVAL RATE;

EID: 82955163284     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.04.006     Document Type: Article

References (46)

1. Fox R.I. Sjögren's syndrome. Lancet 2005, 366:321-331.
2. Kassan S.S., Moutsopoulos H.M. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004, 164:1275-1284.
3. Ramos-Casals M., Solans R., Rosas J., Camps M.T., Gil A., Del Pino J., et al. Primary Sjögren syndrome in Spain: Clinical and immunological expression of 1010 patients. Medicine (Baltimore) 2008, 87:210-219.
4. Moutsopoulos H.M., Zerva L.V. Anti-Ro (SS-A)/La (SS-B) antibodies and Sjogren's syndrome. Clin Rheumatol 1990, 9(Suppl 1):123-130.
5. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in Primary Sjögren Syndrome. Medicine 2009, 88:284-293.
6. Kassan S.S., Thomas T.L., Moutsopoulos H.M., Hoover R., Kimberly R.P., Budman D.R., et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978, 89:888-892.
7. Voulgarelis M., Dafni U.G., Isenberg D.A., Moutsopoulos H.M. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study. Arthritis Rheum 1999, 42:1765-1772. Members of the European Concerted Action on Sjögren's syndrome.
8. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.
9. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L.T.H. Lymphoma and other malignancies in Sögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006, 65:796-803.
10. Brito-Zerón P., Ramos-Casals M., Bove A., Sentis J., Font J. Predicting adverse outcomes in primary Sjögrens's syndrome: identification of prognostic factors. Rheumatology 2007, 46:1359-1362.
11. Anaya J.M., McGuff S., Banks P.M., Talal N. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum 1996, 25:337-346.
12. Tzioufas A.G., Boumba D.S., Skopouli F.N., Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996, 39:767-772.
13. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjogren's syndrome. Arthritis Rheum 1993, 36:340-347.
14. Pathology and genetics: tumours of the hematopoietic and lymphoid tissues. Word Health Organization classification of tumours 2001, LARC Press, Lyon. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (Eds.).
15. Cheson B.D., Pfstner B., Malik E.J., Juweid M.E., Gascoyne R.D., Specht L., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007, 25:579-586.
16. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
17. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide (IARC Cancer Base No. 5) 2001, IARC Press, Lyon, Version 1.0. J. Ferlay, F. Bray, P. Pisany, D.M. Parkin (Eds.).
18. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
19. Zintzaras E., Voulgarelis M., Moutsopoulos H.M. The risk of lymphoma development in autoimmune diseases. Arch Intern Med 2005, 165:2337-2344.
20. Tonami H., Matoba M., Kuginuki Y., Yokota H., Higashi K., Yamamoto I., et al. Clinical and imaging findings of lymphoma in patients with Sjögren syndrome. J Comput Assist Tomogr 2003, 27:517-524.
21. Smebdy K.E., Hjalgrim H., Askling J., Chang E.T., Gregersen H., Porwit-MacDonald A., et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006, 98:51-60.
22. Skopouli F.N., Dafni U., Ioannidis J.P.A., Moutsopoulos H.M. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000, 29:296-304.
23. Ramos-Casals M., Brito-Zeron P., Yagüe J., Akasbi M., Bautista R., Ruano M., et al. Hypocomplementemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome. Rheumatol 2005, 44:89-94.
24. Carroll M.C. The complement system in B cell regulation. Mol Immunol 2004, 41:141-146.
25. Hansen A., Lipsky P.E., Dörner T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007, 9:218-230.
26. Zeher M., Szodoray P., Gyimesi E., Szondy Z. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome. Arthritis Rheum 1999, 42:1673-1681.
27. Smith C., Lilly S., Mann K.P., Livingston E., Myers S., Lyerly H.K., et al. AIDS-related malignancies. Ann Med 1998, 4:323-344.
28. Mariette X. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulations of rheumatoid factor B cells. Ann Rheum Dis 2001, 60:107-110.
29. Pertovaara M., Pukkala E., Laippala P., Miettinen A., Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological and epidemiological aspects. Ann Rheum Dis 2001, 60:467-472.
30. Gottenberg J.E., Busson M., Cohen-Solal J., Lavie F., Abbed K., Kimberly R.P., et al. Correlation of serum B lymphocyte stimulator and B2 microglobulin with autoantibody secretion and systemic involvement in pSS. Arthritis Rheum 2005, 64:1050-1055.
31. Gui W., Wang T., Wang J., Wang L., He J., Yang B., et al. An improved prognostic parameter for non-Hodgkin's lymphoma based in the combination of three serum tumor markers. Int J Biol Markers 2008, 23:207-213.
32. De Vita S., Boiocchi M., Sorrentino D., Carbone A., Avellini C., Dolcetti R., et al. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997, 40:318-331.
33. Youinou P., Devauchelle-Pensec V., Pers J.O. Significance of B cell clonality in Sjögren's syndrome. Arthritis Rheum 2010, 62:2605-2610.
34. Bahler D.W., Sberdlow S.H. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansion. Blood 1998, 91:1864-1872.
35. Bombardieri M., Barone F., Humby F., Kelly S., McGurk M., Morgan P., et al. Activation-induced cytidine-deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome. J Immunol 2007, 179:4929-4938.
36. Ferreri A.J.M., Dolcetti R., Du M.Q., Giordano Resti A., Politi L.S., De Conciliis C., et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 2008, 19:835-846.
37. Royer B., Cazals-Hatem D., Sibilia J., Agbalika F., Cayuela J.M., Soussi T., et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997, 90:766-775.
38. Friedman D.F., Cho E.A., Goldman J., Carmark C.E., Besa E.C., Hardy R.R., et al. The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med 1991, 174:525-537.
39. Chang J.K.C., Mg S.C., Isaacson P.G. Relationship between high grade lymphoma and low grade B-cell mucosa associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990, 136:1153-1164.
40. Dong L., Masaki Y., Takegami T., Jin Z.X., Huang C.R., Fukushima T., et al. Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome. Clin Exp Immunol 2007, 150:279-284.
41. Klussmann J.P., Wagner M., Guntinas-Lichius O., Muller A. Detection of HHV-8 sequences and antigens in a MALT lymphoma associated with Sjögren's syndrome. Oral Pathol Med 2003, 32:243-245.
42. Nishimura M., Miyajima S., Okada N. Salivary gland MALT lymphoma associated with Helycobacter Pylori infection in a patient with Sjögren's syndrome. J Dermatol 2000, 27:450-452.
43. Ferreri A.J., Guidoboni M., Ponzoni M., De Conciliis C., Dell'Oro S., Fleischhauer K., et al. Evidence for an association between Chlamydia psitacii and ocular adnexal lymphomas. J Natl Cancer Inst 2004, 96:586-594.
44. Oldstone M.B. Molecular mimicry and immune-mediated diseases. FASEB J 1998, 12:71-75.
45. Parsonnet J., Hansen S., Rodriguez L., Gelb A.B., Warnke R.A., Jellum E., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994, 330:1267-1270.
46. Yakushijin Y., Kodama T., Takaoka I., Tanimoto K., Bessho H., Sakai I., et al. Absence of chlamydial infection in Japanese patients with adnexal ocular lymphoma of mucosa-associated lymphoid tissue. Int J Hematol 2007, 85:223-230.